Halozyme Therapeutics
HALO
#2187
Rank
NZ$15.75 B
Marketcap
NZ$132.85
Share price
3.20%
Change (1 day)
54.87%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): NZ$0.79 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$1.39 Billion. a decrease over its 2024 earnings that were of NZ$0.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.82 B-16.2%
2024 NZ$0.98 B59.94%
2023 NZ$0.61 B39.94%
2022 NZ$0.44 B0.16%
2021 NZ$0.44 B92.2%
2020 NZ$0.22 B-278.96%
2019 -NZ$0.13 Billion-9.45%
2018 -NZ$0.15 Billion-229.51%
2017 NZ$0.10 B-160.48%
2016 -NZ$0.19 Billion216.03%
2015 -NZ$57.13 Million-52.86%
2014 -NZ$0.13 Billion-18.09%
2013 -NZ$0.15 Billion55.88%
2012 -NZ$94.92 Million169.94%
2011 -NZ$35.17 Million-63.44%
2010 -NZ$96.17 Million-7.19%
2009 -NZ$0.11 Billion15.91%
2008 -NZ$89.39 Million83.89%
2007 -NZ$48.61 Million78.1%
2006 -NZ$27.3 Million16%
2005 -NZ$23.53 Million45.24%
2004 -NZ$16.2 Million682.42%
2003 -NZ$2.08 Million1659.12%
2002 -NZ$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.04 B 5,464.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.77 B 2,168.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.16 B 6,566.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.57 B 1,540.37%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-NZ$0.91 Billion-208.81%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$2.49 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA